Overview
AV node ablation is one of the shortest procedures we do in the lab, but it has the biggest downstream commitment for the patient: lifelong pacemaker dependence. We perform it when rate control of AF, atrial flutter, or other atrial tachycardias has failed despite optimized medical therapy, and the patient already has — or is receiving — a ventricular pacing system (RV-only, CRT, or conduction-system pacing).
Indications
- Symptomatic, drug-refractory rapid ventricular response in persistent or permanent AF
- Tachycardia-mediated cardiomyopathy where rhythm control is not feasible
- Inappropriate ICD shocks driven by rapidly conducted AF after antiarrhythmic optimization
- CRT non-response due to low biventricular pacing percentage from breakthrough AF conduction
Pre-procedure prep
- Confirm device status. If a pacemaker or CRT is already in place, interrogate the morning of the case and document RV (or LV) capture threshold, sensing, and impedance. Borderline thresholds get re-checked before we ablate.
- If the device is being implanted at the same session, complete the implant and confirm acceptable parameters before moving to ablation.
- INR or DOAC plan reviewed. AVN ablation does not require interruption of anticoagulation for AF — continue uninterrupted in most cases.
- NPO per institutional protocol; large-bore peripheral IV; type and screen not routinely required.
- Pre-procedure ECG and rhythm strip in the chart.
Sterile setup
- Right femoral venous access only — single 8 Fr sheath is typical.
- Standard groin prep and drape; a single-site case so no need for full chest field unless device implant is combined.
- Have a temporary pacing wire and external pacing pads on the patient as backup in case of device malfunction during the case.
Equipment
- 8 Fr femoral venous sheath
- Steerable ablation catheter, 4 mm or 8 mm tip (irrigated not required for most cases)
- RF generator with temperature and power monitoring
- EP recording system with surface ECG and intracardiac electrograms
- Programmer for the patient’s pacemaker or ICD
- Fluoroscopy with LAO and RAO views
- External defibrillator pads, transcutaneous pacing capability
- Standard ACLS cart
Technique
- Vascular access under ultrasound guidance, single venous sheath.
- Pace the device asynchronously (VOO or DOO at 80–90 bpm) before ablation so that transient AV block does not produce a pause. Document the change in the device tracking sheet.
- Map the His on the tricuspid annulus from a right-sided approach. We want a clear His electrogram with a small atrial and large ventricular signal.
- Pull back slightly toward the AV node — the target is a position with a larger A and a smaller H (the compact AV node), typically 1–2 cm proximal to a robust His signal.
- Deliver RF at 40–50 W, temperature limit 60–65 °C, for 30–60 seconds. Look for junctional rhythm within the first 10–15 seconds — this is the marker of effective lesioning.
- Confirm complete block. Once AV block is achieved, observe for 10–15 minutes to ensure it is durable. If conduction returns, re-map and re-ablate.
- Restore device programming to a paced rate of 80–90 bpm (we will keep this elevated for 1–3 months).
Threshold and endpoint targets
- Junctional rhythm during ablation is expected and reassuring.
- Endpoint is sustained complete AV block with the patient pacing reliably and no retrograde conduction.
- If we get accelerated junctional rhythm without block, stop, reposition slightly distally, and re-energize.
Complications
- Loss of ventricular pacing — the catastrophic complication; mitigated by pre-ablation device check and asynchronous pacing
- Pause-dependent polymorphic VT in the early post-procedure window — mitigated by the 80–90 bpm pacing strategy
- Femoral hematoma, AV fistula, pseudoaneurysm
- Inadvertent block of the His rather than the AV node (rarely clinically important since we are creating block intentionally)
Post-procedure orders
- Bed rest with groin pressure per protocol; ambulate at 2–3 hours
- Telemetry overnight in most cases
- Device check the next morning to confirm pacing percentage, capture threshold, and sensing
- Discharge instructions: no driving for 24 hours; pacemaker-dependent precautions reviewed
- Follow-up device interrogation in 2 weeks, then per device clinic schedule
- Reduce paced lower rate to a physiologic 60 bpm at the 1–3 month visit